Work Practices of Nurses Who Handle: Antineoplastic Agents

Ames B.N. McCann J. & Yamasaki E. (1975). Methods for detecting carcinogens and mutagens with the salmonella/mammalian microsome mutagenicity test. Mutation Research, 31, 347–364.

Anderson R.W. Puckett W. Dana W. Nguyen T. Theiss J. , & Matney T. (1982). Risk of handling injectable antineoplastic agents. American Journal of Hospital Pharmacy 39, 1881–1887.

Bos R. Leenaars A. Theuws J. , & Henderson P. (1982). Mutagenicity of urine from nurses handling cytostatic drugs. International Archives of Occupational Environmental Health, 50, 359–369.

Brier K. Latiolais C. Scheider P. Moore T. Bueschling W. , & Wentworth B. (1981). Effect of laminar air-flow and clean room dress on contamination rates of intravenous admixtures. American Journal of Hospital Pharmacy 38, 1144–1147.

Chabner B. (1977). Second neoplasm — A complication of cancer chemotherapy. New England Journal of Medicine, 297, 213–215.

Council on Scientific Affairs. (1985). Guidelines for handling parenteral antineoplastics. Journal of the American Medical Association, 253, 1590–1592.

Crudi C.B. (1980). A compounding dilemma: I've kept the drug sterile but have I contaminated myself? National Intravenous Therapy Association, Inc., 3, 77–78.

Dale G. & Smith R. (1974). Transitional cell carcinoma of the bladder associated with cyclophosphamide. Urology 112, 603–604.

Devoret R. (1979). Bacterial tests for potential carcinogens. Scientific American, 241, 40–49.

Donner A. (1978). Possible risk of working with antineoplastic drugs in horizontal laminar flow hoods. American Journal of Hospital Pharmacy 35, 900.

Falck K. Grohn P. Sorsa M. Vainio H. Heinonen E. , & Holsti L. (1979). Mutagenicity of urine of nurses handling cytostatic drugs (letter). Lancet, 1, 1250–1251.

Gibson J.F. Gompertz D. , & Hedworth-Whitty R. (1984). Mutagenicity of urine from nurses handling cytotoxic drugs. Lancet, 1, 100–101.

Goodman L.S. & Gilman A. (1984). The pharmacological basis of therapeutics. New York: Macmillan Publishing Co., Inc.

Harrison B. (1981). Developing guidelines for working with antineoplastic drugs. American Journal of Hospital Pharmacy, 38, 1686–1693.

Heidelberger C. (1977). Chemical carcinogenesis. Cancer, 40, 430–433.

Hillcoat B. Levi J. , & Snyder R. (1983, April 30). Preparation and administration of antineoplastic agents. The Medical Journal of Australia, 1, 424–426.

Hirst M. Mills D. Tse S. , & Levin L. (1984). Occupational exposure to cyclophosphamide. Lancet, 1, 186–188.

Hoffman D. (1980). The handling of antineoplastic drugs in a major cancer center. Hospital Pharmacy 15, 301–303.

Hoffman D.M. (1983). Lack of urine mutagenicity of nurses administering pharmacy prepared doses of antineoplastic agents. American Journal of Intravenous Therapy and Clinical Nutrition, 1, 28–31.

Hoover R. & Fraumeni J. (1981). Drug-induced cancer. Cancer, 47, 1071–1080.

Horning S. Hoppe R. Kaplan H. , & Rosenberg S. (1981). Female reproductive potential after treatment for Hodgkin's disease. New England Journal of Medicine, 304, 1377–1382.

Jagun O. Ryan M. , & Waldron H. (1982). Urinary thioether excretion in nurses handling cytotoxic drugs. Lancet, 1, 443–444.

Karp G. Oeyen P. Valone F. Khetarpal V Israel M. Mayer R. Frigoletto F. , & Garnick H. (1983). Doxorubicin in pregnancy: Possible transplacental passage. Cancer Treatment Reports, 67, 773–777.

Knowles R. & Virden J. (1980). Handling of injectable antineoplastic agents. British Medical Journal, 28(30), 589–591.

Kolmodin-Hedman B. Harlvig P. Sorsa M. , & Falck K. (1983). Occupational handling of cytostatic drugs. Archives of Toxicology, 54, 25–33.

Ladik C.F. Stoehr G.P. & Maurer M.A. (1980). Precautionary measures in the preparation of antineoplastics (letter). American Journal of Hospital Pharmacy, 37, 1184–1186.

LeRoy M. Roberts M. , & Theisen J. (1983). Procedures for handling antineoplastic injections in comprehensive cancer centers. American Journal of Hospital Pharmacy 40, 601–603.

Leyden M. & Sullivan J. (1982). Full-thickness skin necrosis due to inadvertent infusion of cisplation. Cancer Treatment Reports, 67, 199.

Musilova J. Michalova K. , & Urban J. (1979). Sister chromatid exchanges and chromosomal breakage in patients treated with cytostatics. Mutation Research, 67, 289–294.

National Study Commission on Cytotoxic Exposure. (1983). Recommendations for handling cytotoxic agents. Department of Pharmacy Rhode Island Hospital, Providence, Rhode Island.

Nguyen T.V. Theiss J. , & Matney T. (1982). Exposure of pharmacy personnel to mutagenic antineoplastic drugs. Cancer Research, 42, 4792–4796.

Nikula E. Kivinitty K. , & Leist J. (1984). Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scandinavian Journal of Work and Environmental Health, 10, 71.

Norppa H. Sorsa M. Vainio H. Grohn P. Heinonen E. Holsti L. , & Nordman E. (1980). Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scandinavian Journal of Work and Environmental Health, 6, 299–301.

Olver I. & Schwarz M. (1982). Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin. Cancer Treatment Reports, 67, 407–408.

Oncology Nursing Society. (1984). Cancer chemotherapy: Guidelines and recommendations for nursing education and practice. Pittsburgh.

Reimer R. Hoover R. Frawmeni J. , & Young R. (1977). Acute leukemia after alkylating agent therapy of ovarian cancer. New England Journal of Medicine, 297, 177–181.

Rogers B. (1985). Urine mutagenicity of nurses who handle antineoplastic agents at work (Dissertation).

Rogers B. (1986). Antineoplastic agents: Action and toxicities. AAOHN Journal, 34(11), 530–538.

Selevan S. Lindbohm M. Polsci C. Hornung R. , & Hemminki K. (1985). A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine, 313, 1173–1178.

Sotaniemi E.A. Sutinen S. Arranto A. Sutinen S. Sotaniemi K. Lehtola J. , & Pelkonen R. (1983). Liver damage in nurses handling cytostatic agents. Acta Med Scand, 214, 181–189.

Stellman J. Aufiero B. , & Taub R. (1982). Assessment of potential exposure to antineoplastic agents in the health care setting. Preventive Medicine, 13, 245–255.

Stiller A. Obe G. Boll I. , & Pribilla W. (1983). No elevation of the frequencies of chromosomal alteration as a consequence of handling cytostatic drugs. Analyses with peripheral blood and urine of hospital personnel. Mutation Research, 121, 253–259.

Stucker I. Hirsch A. Doloy T. Bastic-Sigeac I. , & Hemon D. (1986). Urine mutagenicity chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. International Archives of Occupational and Environmental Health, 57, 195–205.

Tortorici M. (1980). Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications. Hospital Pharmacy 15, 294–353.

U.S. Department of Labor (1986). Guidelines for cytotoxic (antineoplastic) drugs. (OSHA Pub. 8.1.1) Washington, D.C.

U.S. Department of Labor (1983). Bureau of Labor Statistics.

Valanis B. & Browne M. (1985). Use of protection by nurses during occupational handling of antineoplastic drugs. NITA, 8, 218–222.

Vaughan M. & Christensen W. (1985). Occupational exposure to cancer chemotherapeutic drugs: A literature review. American Industrial Hygiene Association Journal, 46, 8–12.

Venitt S. Crofton-Sleigh C. Hunt J. Speechley V. , & Briggs K. (1984). Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: Urinary mutation assays and urinary platinum as markers of absorption. Lancet, 1, 74–77.

Waksvik H. (1981). Chromosome analyses of nurses handling cytostatic agents. Cancer Treatment Reports, 65, 607–610.

Wall R. & Clausen K. (1975). Carcinoma of the urinary bladder in patients receiving cyclophosphamide. New England Journal of Medicine, 293, 271–273.

Wilson J.P. & Solimando D.A. (1981). Antineoplastics: A safety hazard? (letter). American Journal of Hospital Pharmacy, 38, 624.

Wolff S. (1983). Sister chromatid exchange as a test for mutagenic carcinogens. Annals of the New York Academy of Sciences, 83, 142–153.

Zimmerman P. Larsen R. Barkley E. , & Gallelli J. (1981). Recommendations for safe handling of injectable antineoplastic drug products. American Journal of Hospital Pharmacy, 38, 1693–1695.